SATOF yields 3.11% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, SATOF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SATOF + JNJ for your $10,000?
Sato Holdings Corporation engages in the manufacture and sale of labeling products in Japan and internationally. It offers printers, consumables, cloud-based preventative maintenance solution, hand labelers, stickers and primary labels, primary package consulting, radio frequency identification tags, troubleshooting assistance, and maintenance services. The company also provides various solutions, such as hardware, consumables, maintenance services and software, demonstrating ROI, and other services; SATO online services, a cloud-based monitoring services for printers that enable preventive maintenance and on-the-spot troubleshooting; and develops application software and enables integration with ERP, WMS, and MDM systems. It serves retail, manufacturing, food, logistics, health care, postal, government/municipal offices, utilities, education, and public transit industries. Sato Holdings Corporation was founded in 1940 and is headquartered in Tokyo, Japan.
Full SATOF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.